Erlotinib overcomes paclitaxel-resistant cancer stem cells by blocking the EGFR-CREB/GRβ-IL-6 axis in MUC1-positive cervical cancerYaping Lv(Shanghai Jiao Tong University), Lei Huang(Shanghai Jiao Tong University)OncogenesisNovember 26, 201910.1038/s41389-019-0179-2Cited by 42SaveCiteExport RISWatch citationsRelated PapersMUC1 induces acquired chemoresistance by upregulating ABCB1 in EGFR-dependent manner|Cell Death and Disease|2017|92The Cytoplasmic Domain of MUC1 Induces Hyperplasia in the Mammary Gland and Correlates with Nuclear Accumulation of β-Catenin|PLoS ONE|2011|21